Getting Chronic Kidney Disease on the Map
View More View Less
  • 1 Renal Division, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
  • | 2 Department of Paediatrics and Child Health, University of Cape Town, Cape Town, South Africa
  • | 3 Department of Nephrology, University Children’s Hospital, Zürich, Switzerland
  • 1

    World Health Organization: The top 10 causes of death, 2020. Available at https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death. Accessed April 30, 2021

    • Crossref
    • Export Citation
  • 2

    Jager KJ, Kovesdy C, Langham R, Rosenberg M, Jha V, Zoccali C: A single number for advocacy and communication-worldwide more than 850 million individuals have kidney diseases. Kidney Int 96: 10481050, 2019 10.1016/j.kint.2019.07.012

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 3

    Luyckx VA, Cherney DZI, Bello AK: Preventing CKD in developed countries. Kidney Int Rep 5: 263277, 2019 10.1016/j.ekir.2019.12.003PubMed

    • Search Google Scholar
    • Export Citation
  • 4

    Lewington AJ, Cerdá J, Mehta RL: Raising awareness of acute kidney injury: A global perspective of a silent killer. Kidney Int 84: 457467, 2013 10.1038/ki.2013.153PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 5

    International Society of Nephrology: Global Kidney Health Atlas: A Report by the International Society of Nephrology on the Global Burden of End-Stage Kidney Disease and Capacity for Kidney Replacement Therapy and Conservative Care across World Countries and Regions, Brussels, Belgium, International Society of Nephrology, 2019

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 6

    Bikbov B, Perico N, Remuzzi G; on behalf of the GBD Genitourinary Diseases Expert Group: Disparities in chronic kidney disease prevalence among males and females in 195 countries: Analysis of the Global Burden of Disease 2016 Study. Nephron 139: 313318, 2018 10.1159/000489897PubMed

    • Search Google Scholar
    • Export Citation
  • 7

    GBD Chronic Kidney Disease Collaboration: Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 395: 709733, 2020 10.1016/s0140-6736(20)30045-3PubMed

    • Search Google Scholar
    • Export Citation
  • 8

    Institute for Health Metrics and Evaluation: GBD Compare/Viz Hub, 2021. Available at: https://vizhub.healthdata.org/gbd-compare/. Accessed April 30, 2021

  • 9

    International Society of Nephrology: KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Available at https://kdigo.org/wp-content/uploads/2017/02/KDIGO_2012_CKD_GL.pdf. Accessed April 30, 2021

    • Search Google Scholar
    • Export Citation
  • 10

    International Society of Nephrology: Global Kidney Health Atlas: A report by the International Society of Nephrology on the current state of organization and structures for kidney care across the globe. Available at https://www2.theisn.org/GKHA. Accessed April 30, 2021

    • Crossref
    • Export Citation
  • 11

    GBD 2019 Risk Factor Collaborators: The Lancet: Latest global disease estimates reveal perfect storm of rising chronic diseases and public health failures fuelling COVID-19 pandemic, 2021. Available at: http://www.healthdata.org/news-release/lancet-latest-global-disease-estimates-reveal-perfect-storm-rising-chronic-diseases-and. Accessed April 30, 2021

    • Crossref
    • Export Citation
  • 12

    Liyanage T, Ninomiya T, Jha V, Neal B, Patrice HM, Okpechi I, et al.: Worldwide access to treatment for end-stage kidney disease: A systematic review. Lancet 385: 19751982, 2015 10.1016/s0140-6736(14)61601-9PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 13

    Yeung E, Bello AK, Levin A, Lunney M, Osman MA, Ye F, et al.: Current status of health systems financing and oversight for end-stage kidney disease care: A cross-sectional global survey. BMJ Open 11: e047245, 2021 10.1136/bmjopen-2020-047245PubMed

    • Search Google Scholar
    • Export Citation
  • 14

    Bello AK, Levin A, Lunney M, Osman MA, Ye F, Ashuntantang GE, et al.: Status of care for end stage kidney disease in countries and regions worldwide: International cross sectional survey. BMJ 367: l5873, 2019 10.1136/bmj.l5873PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 15

    Luyckx VA: Ethical Challenges Relating to Provision of Sustainable Renal Care in Resource Limited Settings–Focus on Sub-Saharan Africa PhD thesis, University of Zurich, 2019.

    • Crossref
    • Export Citation
  • 16

    GBD 2017 Causes of Death Collaborators: Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet 392: 17361788, 2018 10.1016/s0140-6736(18)32203-7PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 17

    Garcia-Garcia G, Jha V; World Kidney Day Steering Committee: CKD in disadvantaged populations. Kidney Int 87: 251253, 2015 10.1038/ki.2014.369PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 18

    Luyckx VA, Tonelli M, Stanifer JW: The global burden of kidney disease and the sustainable development goals. Bull World Health Organ 96: 414422D, 2018 10.2471/BLT.17.206441PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 19

    Stutzin Donoso F: Chronic disease as risk multiplier for disadvantage. J Med Ethics 44: 371375, 2018 10.1136/medethics-2017-104321PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 20

    Luyckx VA, Al-Aly Z, Bello AK, Bellorin-Font E, Carlini RG, Fabian J, et al.: Sustainable Development Goals relevant to kidney health: An update on progress. Nat Rev Nephrol 17: 1532, 2021 10.1038/s41581-020-00363-6PubMed

    • Search Google Scholar
    • Export Citation
  • 21

    Nishtar S, Niinistö S, Sirisena M, Vázquez T, Skvortsova V, Rubinstein A, et al.; Commissioners of the WHO Independent High-Level Commission on NCDs: Time to deliver: Report of the WHO Independent High-Level Commission on NCDs. Lancet 392: 245252, 2018 10.1016/S0140-6736(18)31258-3PubMed

    • Search Google Scholar
    • Export Citation
  • 22

    World Health Organization: Global Action Plan for the prevention and control of noncommunicable diseases 2013-2020. Available at: http://www.who.int/nmh/events/ncd_action_plan/en/. Accessed April 30, 2021

    • Crossref
    • Export Citation
  • 23

    Harper T, Ghebreyesus TA, Fore H, Ulstein D-I: Building back better: Investing in healthy populations and resilient health systems for NCDs and mental health to be better prepared for future crises, 2021. Available at: https://foresightglobalhealth.com/investing-in-healthy-populations-and-resilient-health-systems-for-ncds-and-mental-health-to-be-better-prepared-for-future-crises/. Accessed April 30, 2021

    • Crossref
    • Export Citation
  • 24

    Luyckx VA: Equity is key to build back better after COVID-19: Prioritize noncommunicable diseases and kidney health. Kidney360 2: 747750, 2021 10.34067/KID.0006932020PubMed

    • Search Google Scholar
    • Export Citation
  • 25

    Foreman KJ, Marquez N, Dolgert A, Fukutaki K, Fullman N, McGaughey M, et al.: Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: Reference and alternative scenarios for 2016-40 for 195 countries and territories. Lancet 392: 20522090, 2018 10.1016/s0140-6736(18)31694-5PubMed

    • Search Google Scholar
    • Export Citation
  • 26

    United Nations: Sustainable Development Goals, 2020. Available at: https://www.un.org/sustainabledevelopment/. Accessed April 30, 2021

    • Crossref
    • Export Citation
  • 27

    World Health Organization: Saving lives, spending less: A strategic response to noncommunicable diseases, 2018. Available at: https://www.who.int/ncds/management/ncds-strategic-response/en/. Accessed April 30, 2021

    • Crossref
    • Export Citation
  • 28

    Thomas LM, D’Ambruoso L, Balabanova D: Verbal autopsy in health policy and systems: A literature review. BMJ Glob Health 3: e000639, 2018 10.1136/bmjgh-2017-000639PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 29

    Bello AK, Ronksley PE, Tangri N, Kurzawa J, Osman MA, Singer A, et al.: Quality of chronic kidney disease management in Canadian primary care. JAMA Netw Open 2: e1910704, 2019 10.1001/jamanetworkopen.2019.10704PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 30

    Tonelli M, Dickinson JA: Early detection of CKD: Implications for low-income, middle-income, and high-income countries. J Am Soc Nephrol 31: 19311940, 2020 10.1681/ASN.2020030277PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 31

    Htay H, Alrukhaimi M, Ashuntantang GE, Bello AK, Bellorin-Font E, Benghanem Gharbi M, et al.: Global access of patients with kidney disease to health technologies and medications: Findings from the Global Kidney Health Atlas project. Kidney Int Suppl (2011) 8: 6473, 2018 10.1016/j.kisu.2017.10.010

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 32

    Bernabé-Ortiz A, Zafra-Tanaka JH, Moscoso-Porras M, Sampath R, Vetter B, Miranda JJ, et al.: Diagnostics and monitoring tools for noncommunicable diseases: A missing component in the global response. Global Health 17: 26, 2021 10.1186/s12992-021-00676-6PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 33

    Velazquez Berumen A, Garner S, Hill SR, Swaminathan S: Making diagnostic tests as essential as medicines. BMJ Glob Health 3: e001033, 2018 10.1136/bmjgh-2018-001033PubMed

    • Search Google Scholar
    • Export Citation
  • 34

    Levin A, Tonelli M, Bonventre J, Coresh J, Donner JA, Fogo AB, et al.; ISN Global Kidney Health Summit participants: Global kidney health 2017 and beyond: A roadmap for closing gaps in care, research, and policy. Lancet 390: 18881917, 2017 10.1016/S0140-6736(17)30788-2PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 35

    World Health Organization: HEARTS Technical Package, 2018. Available at: http://www.who.int/cardiovascular_diseases/hearts/en/. Accessed May 5, 2021

    • Crossref
    • Export Citation
  • 36

    Vanholder R, Annemans L, Brown E, Gansevoort R, Gout-Zwart JJ, Lameire N, et al.; European Kidney Health Alliance: Reducing the costs of chronic kidney disease while delivering quality health care: a call to action. Nat Rev Nephrol 13: 393409, 2017 10.1038/nrneph.2017.63PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 37

    Luyckx VA, Tuttle KR, Garcia-Garcia G, Gharbi MB, Heerspink HJL, Johnson DW, et al.: Reducing major risk factors for chronic kidney disease. Kidney Int Suppl (2011) 7: 7187, 2017 10.1016/j.kisu.2017.07.003

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 38

    Wirtz VJ, Hogerzeil HV, Gray AL, Bigdeli M, de Joncheere CP, Ewen MA, et al.: Essential medicines for universal health coverage. Lancet 389: 403476, 2017 10.1016/S0140-6736(16)31599-9PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 39

    Chow CK, Nguyen TN, Marschner S, Diaz R, Rahman O, Avezum A, et al.; PURE Study: Availability and affordability of medicines and cardiovascular outcomes in 21 high-income, middle-income and low-income countries. BMJ Glob Health 5: e002640, 2020 10.1136/bmjgh-2020-002640PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 40

    Khatib R, McKee M, Shannon H, Chow C, Rangarajan S, Teo K, et al.; PURE study investigators: Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: An analysis of the PURE study data. Lancet 387: 6169, 2016 10.1016/S0140-6736(15)00469-9PubMed

    • Search Google Scholar
    • Export Citation
  • 41

    Jan S, Laba TL, Essue BM, Gheorghe A, Muhunthan J, Engelgau M, et al.: Action to address the household economic burden of non-communicable diseases. Lancet 391: 20472058, 2018 10.1016/s0140-6736(18)30323-4PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 42

    Essue BM, et al.: Disease Control Priorities. Improving Health and Reducing Poverty, edited by Jamison DT, et al., Vol. 9, Washington, DC, World Bank, 2018, pp 121143

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 43

    Essue BM, Wong G, Chapman J, Li Q, Jan S: How are patients managing with the costs of care for chronic kidney disease in Australia? A cross-sectional study. BMC Nephrol 14: 5, 2013 10.1186/1471-2369-14-5PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 44

    Kruk ME, Gage AD, Joseph NT, Danaei G, García-Saisó S, Salomon JA: Mortality due to low-quality health systems in the universal health coverage era: A systematic analysis of amenable deaths in 137 countries. Lancet 392: 22032212, 2018 10.1016/s0140-6736(18)31668-4PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 45

    Kruk ME, Gage AD, Arsenault C, Jordan K, Leslie HH, Roder-DeWan S, et al.: High-quality health systems in the Sustainable Development Goals era: Time for a revolution. Lancet Glob Health 6: e1196e1252, 2018 10.1016/S2214-109X(18)30386-3PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 46

    Vanholder R, Annemans L, Bello AK, Bikbov B, Gallego D, Gansevoort RT, et al.: Fighting the unbearable lightness of neglecting kidney health: The decade of the kidney. Clin Kidney J 14: 17191730, 2021 10.1093/ckj/sfab070PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 47

    Bignall ONR 2nd, Crews DC: Stony the road we trod: Towards racial justice in kidney care. Nat Rev Nephrol 17: 7980, 2021 10.1038/s41581-020-00389-wPubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 48

    Kevin Tucker J: Social justice as a tool to eliminate inequities in kidney disease. Semin Nephrol 41: 203210, 2021 10.1016/j.semnephrol.2021.05.001PubMed

    • Search Google Scholar
    • Export Citation
  • 49

    ERA-EDTA Council; ERACODA Working Group: Chronic kidney disease is a key risk factor for severe COVID-19: A call to action by the ERA-EDTA. Nephrol Dial Transplant 36: 8794, 2021 10.1093/ndt/gfaa314PubMed

    • Search Google Scholar
    • Export Citation

Metrics

All Time Past Year Past 30 Days
Abstract Views 382 382 265
Full Text Views 175 175 93
PDF Downloads 242 242 134